Aprogen Medicines Inc. (KRX:007460)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2012	FY 2011
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2012	Dec 31, 2011
Hard Facing	-		13.41B	-	29.26B	32.30B
Hard Facing Growth	-		-	-	-9.42%	-6.15%
Steel	-		19.42B	-	34.62B	10.28B
Steel Growth	-		-	-	236.84%	36.84%
Insulation (Including NUKON)	-		2.74B	-	7.17B	6.90B
Insulation (Including NUKON) Growth	-		-	-	3.98%	-12.41%
Medicine	60.12B		32.47B	-	50.80B	25.67B
Medicine Growth	-		-	-	97.84%	-
Biopharmaceuticals	-		9.39B	25.87B	-	-
Biopharmaceuticals Growth	-		-63.69%	-	-	-
Other Sales	57.49M		769.50M	425.33M	2.77B	1.89B
Other Sales Growth	-		80.92%	-84.65%	46.34%	52.75%
Bio Sector	2.35B		-	-	-	-
Metal Sector	79.13B		-	-	-	-
Insulation Business Division	8.46B		-	-	-	-
Game Business Division	-		148.30M	-	2.52B	1.20B
Game Business Division Growth	-		-	-	110.23%	-
Total	150.11B		78.35B	26.30B	127.14B	78.25B
Total Growth	-		197.95%	-79.32%	62.48%	53.29%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2012	FY 2011
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2012	Dec 31, 2011
South Korea	139.72B		68.71B	479.85M	112.40B	-
South Korea Growth	-		14220.02%	-99.57%	-	-
Export	10.39B		9.63B	25.82B	12.02B	-
Export Growth	-		-62.68%	114.78%	-	-
Other Areas	-		-	-	2.72B	-
Total	150.11B		78.35B	26.30B	127.14B	-
Total Growth	-		197.95%	-79.32%	-	-

Source: S&P Global Market Intelligence.